This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Net Medical Xpress Announces Q2'2012 And Six Months 2012 Results

ALBUQUERQUE, N.M., Aug. 15, 2012 /PRNewswire/ --  New Mexico Software, Inc. , d/b/a Net Medical Xpress (OTC Bulletin Board NMXC) announced today the company's financial results for the second quarter and the first six months of 2012.

New Mexico Software is a medical services company that provides clinical and diagnostic programs using advanced telemedicine solutions for rural hospitals. The company also develops FDA 510(k) cleared, all-inclusive PACS products for the medical market.

The company reported $961,000 in net sales for the second quarter ended June 30, 2012, a gain of 26.8% over the same period a year earlier. For the quarter, the company reported a net loss of ($12,000) versus a net loss of ($104,000) in the second quarter of 2011.

For the first six months of 2012, the company reported revenue of $1,883,000, a gain of 11.1% over revenue of $1,694,000 in the comparable period a year earlier. For the first six months, the company reported a net loss of ($35,000) versus a net loss in the first six months of 2011 of ($94,000).

Additional details can be found in the company's 10-K filing with the Securities and Exchange Commission.

CEO Dick Govatski said, "The overall numbers don't yet reflect it, but we have entered the most exciting time in the history of our company. In the first half we are recording rapid growth in our Specialist Program and in sales of Specialist Program hardware. Our Specialist Program began operations during the first quarter with a neurology/stroke assessment program at Alta Vista Hospital in New Mexico. It has been a tremendous success for the hospital and for the patients. Since the primary target market for this service is small rural hospitals, we expect that the main growth in this segment will come from regular addition of new customers as opposed to large customers with high volumes of transactions.

"In addition, customers in the Specialist Program are purchasing our videoconferencing hardware necessary for remote diagnosis. Our pipeline of new business is growing quickly and as a result we expect revenues in this category to increase during the remainder of 2012 and on into 2013 as we continue to add new customers. We also continued to see healthy increases in radiology services due to increased volume usage by existing customers. This category continues to be our largest revenue center. We also saw increases in software usage fees due to increased usage by existing customers.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs